Caribou Biosciences

Please note: The information displayed on this page might be outdated.
Caribou Biosciences:
Caribou is a leading company in CRISPR genome editing founded by pioneers of CRISPR biology. The company is developing an internal pipeline of off-the-shelf CAR-T cell therapies, other gene-edited natural killer (NK) cell therapies, and engineered gut microbes.
Investors include: Anterra Capital; Dupont; F-Prime Capital; Genoa Ventures; Genus; Heritage Group; Maverick Ventures; Mission Bay Capital; Novartis
Investors include: Anterra Capital; Dupont; F-Prime Capital; Genoa Ventures; Genus; Heritage Group; Maverick Ventures; Mission Bay Capital; Novartis
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Disease Space
Oncology
Listing
Private
Website:
Profiles:
Address:
2929 7th St., Suite 105
Berkeley, CA 94710
United States
Berkeley, CA 94710
United States
Presentation:
More info:
My account:
Company Participants at Solebury Trout Corporate Access Calls - May 11&12
- Rachel Haurwitz, Ph.D., President/CEO/Co-Founder